Accessibility Statement Skip Navigation
  • Назад к Международным сайтам
  • +44 (0)20 7454 5110
  • GDPR
  • Журналисты
  • Запросить дополнительную информацию
PR Newswire: news distribution, targeting and monitoring
  • Новости
  • Продукция
  • Обратная связь
Search
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News Releases view all

    • Hamburger menu
    • PR Newswire: news distribution, targeting and monitoring
    • Запросить дополнительную информацию
      • Телефон

      • +44 (0)20 7454 5110 от 8 AM - 5 PM GMT

      • Свяжитесь с нами
      • Свяжитесь с нами

        +44 (0)20 7454 5110
        от 8 AM - 5 PM GMT

    • Searching for your content...

      No results found. Please change your search terms and try again.

      News Releases

      view all
      Close menu
    • Новости
    • Продукция
    • Обратная связь
      • Запросить дополнительную информацию
      • Журналисты
      • GDPR
      • General Enquiries
      • Request a Demo
      • Editorial Bureaus
      • Partnership
      • Media Enquiries
      • Worldwide Offices
      • Запросить дополнительную информацию
      • Журналисты
      • GDPR

      Maypharm CO, LTD., launched a new CE filler: Multi-layered Phasic Hyaluronic Acid with lidocaine and CE approved MayFill Filler


      Информация предоставлена

      Maypharm

      20 февр, 2023, 11:44 GMT

      Поделиться этой статьей

      Поделиться этой статьей


      SEOUL, South Korea and NEW YORK, Feb. 20, 2023 /PRNewswire/ -- Maypharm, a brand holder of such popular products as Metoo fill, Sedy fill, Metox, Mennus, Hairna, Eyebella, has been busy with developing new products in Aestheticians market. Metoo Fill is the first CE approved filler made by Maypharm and it is loved by customers for its Excellent Volume and High Viscosity with price compatibility. Clinically Proven, Metoo Fill experienced a ton of exacting clinical preliminaries to guarantee the fillers' performance stays incredible. Metoo Fill has official distributors in such countries as UK, Thailand, Indonesia, Latvia and others. Maypharm's new filler MayFill contains Multi-layered Phasic Hyaluronic Acid based with new R2 Technology (Rotation and Revolution), and lidocaine for comfortable application, unlike Metoo Fill (CE).

      Continue Reading
      Maypharm
      Maypharm
      Maypharm
      Maypharm

      Hyaluronic acid, which is naturally found in the body, works by holding onto water within the skin and increasing the skin's volume. MayFill HA filler should be easy to modify because it reacts quickly to enzymes and normalize unsatisfactory results. The result is smoother, firmer, and more youthful looking skin that can help to erase the years away. Plus, compared to other treatments or devices there is a relatively low risk with minimal downtime and quicker recovery.

      In Multi-layered Phasic hyaluronic acid fillers two layers exist together in the body creating even more natural results over time. That reduces the situation in which cross-linked particles with relatively high recovery power come into direct contact with the treatment area and become unnatural.

      In addition, Mayfill has lowered the incidence of edema. If there is insufficient hydration, edema makes it difficult to predict the procedure, resulting in low patient satisfaction. Mayfill provides sufficient hydration and can be used to contour and sculpt areas of the face, such as the cheekbones, lips, or chin, to create a more symmetrical and balanced look. There are three types of MayFill: Volume, Deep and Light. They are also customizable, so you can choose the amount of product injected and the type of product to use depending on your desired results.

      After success on Asian, UK, Middle East and US market Maypharm continues its growing on African and Southern American market discovering distributors for Sedy fill, Metox, MayFill and Mennus.  

      Visit a website for a detailed information: www.maypharm.net

      Photo - https://mma.prnewswire.com/media/2005740/Maypharm.jpg
      Photo - https://mma.prnewswire.com/media/2005741/Maypharm.jpg

      Modal title

      Also from this source

      MAYPHARM представляет HYALMASS AQUATOX -- мультиактивное решение нового поколения для ухода за кожей, разработанное для мирового рынка эстетической косметологии

      MAYPHARM представляет HYALMASS AQUATOX -- мультиактивное решение нового поколения для ухода за кожей, разработанное для мирового рынка эстетической косметологии

      Компания MAYPHARM, работающая на мировом рынке эстетической косметологии и космецевтики, объявила о предстоящем выпуске HYALMASS AQUATOX — нового...

      MAYPHARM Unveils HYALMASS AQUATOX, a Next-Generation Multi-Active Skin Solution for the Global Aesthetic Market

      MAYPHARM Unveils HYALMASS AQUATOX, a Next-Generation Multi-Active Skin Solution for the Global Aesthetic Market

      MAYPHARM, a global aesthetic and cosmeceutical company, has announced the upcoming launch of HYALMASS AQUATOX, introducing a new multi-active...

      More Releases From This Source

      Способы связи с PR Newswire

      • +44 (0)20 7454 5110
        от 8 AM - 5 PM GMT

      Все сайты

      • APAC
      • APAC - Традиционный китайский
      • Азия
      • Бразилия
      • Канада
      • Чешский
      • Дания
      • Финляндия
      • Франция
      • Германия

       

      • Индия
      • Indonesia
      • Израиль
      • Италия
      • Мексика
      • Средний Восток
      • Средний Восток - арабский
      • Нидерланды
      • Норвегия
      • Польша

       

      • Португалия
      • Россия
      • Словакия
      • Испания
      • Швеция
      • Великобритания
      • Соединенные Штаты

      Do not sell or share my personal information:

      • Submit via [email protected] 
      • Call Privacy toll-free: 877-297-8921
      Все сайты
      • Азия
      • Бразилия
      • Канада
      • Чешский
      • Дания
      • Финляндия
      • Франция
      • Германия
      • Индия
      • Израиль
      • Италия
      • Мексика
      • Middle East
      • Нидерланды
      • Норвегия
      • Польша
      • Португалия
      • Россия
      • Словакия
      • Испания
      • Швеция
      • Великобритания
      • Соединенные Штаты
      +44 (0)20 7454 5110
      от 8 AM - 5 PM GMT
      • Terms of Use
      • Privacy Policy
      • Information Security Policy
      • Site Map
      • Cookie Settings
      Copyright © 2026 Cision US Inc.